Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Specimen Handling 43 pembrolizumab 42 Biopsy 36 Magnetic Resonance Spectroscopy 34 Paclitaxel 21 Carboplatin 21 Gemcitabine 20 Nivolumab 19 Irinotecan 17 Radiosurgery 15 Cisplatin 13 Taxes 11 Pemetrexed 11 Ipilimumab 11 Fluorouracil 11 Cetuximab 11 130-nm albumin-bound paclitaxel 11 trastuzumab deruxtecan 10 olaparib 10 Leucovorin 10 Capecitabine 10 abemaciclib 9 Oxaliplatin 9 Cyclophosphamide 9 Bevacizumab 9 palbociclib 8 durvalumab 8 Fulvestrant 8 X-Rays 7 Trastuzumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Base Sequence × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡